Tīmeklis2024. gada 29. jūn. · Noopur Raje, MD, director of the Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center and a professor of medicine at Harvard Medical School, discusses the rationale for CAR T-cell therapy in multiple myeloma. The field now has a good target with regard to BCMA and most cellular therapy products … TīmeklisIn a randomized phase 3 study of denosumab (XG) vs zoledronic acid (ZA) in patients with newly diagnosed multiple myeloma (MM) (Raje et al. Lancet Oncol 2024), XG was shown to be non-inferior to ZA and had a safety profile comparable to that of ZA with less renal toxicity. The mean treatment duration was 17.5 months for XG, and …
Noopur Raje, MD - Patient Power
Tīmeklis2024. gada 29. aug. · Noopur Raje, MD. The deep and durable phase I responses seen with the anti-BCMA chimeric antigen receptor (CAR) T-cell therapy bb2121 in patients with relapsed/refractory heavily pretreated multiple myeloma have prompted a phase II study, which is currently ongoing, according to Noopur Raje, MD. Tīmeklis2024. gada 22. jūn. · DocWire News spoke with Noopur Raje, MD, Director of the Center for Multiple Myeloma and Professor of Medicine at Harvard Medical School, about how multiple myeloma impacts the kidneys and increases risk for kidney disease, and how these complications can be mitigated and treated. Interview Transcript DW: … thinner standard sinteplast
Noopur Raje, MD - Mass General Advances in Motion
Tīmeklis2024. gada 28. maijs · 8036 Background: Ide-cel, a BCMA-directed CAR T cell therapy, showed promising efficacy in patients (pts) with RRMM in the KarMMa study with an ORR of 73% and a CRR of 33% across target doses of 150–450 × 106 CAR+ T cells (Munshi NC, et al. J Clin Oncol 2024;38[suppl 15]. Abstract 8503). Associations of … TīmeklisPut your team front and center and show candidates how great you really are – it’s free Tīmeklis2024. gada 21. dec. · In this exclusive MedPage Today video, Noopur Raje, MD, director of the Center for Multiple Myeloma at Massachusetts General Hospital in Boston, outlines the results of the study. Following is a ... thinner std